164 related articles for article (PubMed ID: 33748270)
1. DUOX2 As a Potential Prognostic Marker which Promotes Cell Motility and Proliferation in Pancreatic Cancer.
Cao M; Zhang PB; Wu PF; Chen Q; Ge WL; Shi GD; Yin J; Cai BB; Cao SJ; Miao Y; Jiang KR
Biomed Res Int; 2021; 2021():6530298. PubMed ID: 33748270
[TBL] [Abstract][Full Text] [Related]
2. Integrated Analysis of Multi-Omics Data to Identify Prognostic Genes for Pancreatic Cancer.
Jiang F; Huang X; Zhang F; Pan J; Wang J; Hu L; Chen J; Wang Y
DNA Cell Biol; 2022 Mar; 41(3):305-318. PubMed ID: 35104421
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
Han Q; Li J; Xiong J; Song Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
[TBL] [Abstract][Full Text] [Related]
5. Dual oxidase 2 and pancreatic adenocarcinoma: IFN-γ-mediated dual oxidase 2 overexpression results in H2O2-induced, ERK-associated up-regulation of HIF-1α and VEGF-A.
Wu Y; Meitzler JL; Antony S; Juhasz A; Lu J; Jiang G; Liu H; Hollingshead M; Haines DC; Butcher D; Panter MS; Roy K; Doroshow JH
Oncotarget; 2016 Oct; 7(42):68412-68433. PubMed ID: 27637085
[TBL] [Abstract][Full Text] [Related]
6. Expression of Coiled-Coil Domain Containing 34 (CCDC34) and its Prognostic Significance in Pancreatic Adenocarcinoma.
Qi W; Shao F; Huang Q
Med Sci Monit; 2017 Dec; 23():6012-6018. PubMed ID: 29257799
[TBL] [Abstract][Full Text] [Related]
7. PMEPA1 Stimulates the Proliferation, Colony Formation of Pancreatic Cancer Cells via the MAPK Signaling Pathway.
Song M; Zhou B; Li B; Tian L
Am J Med Sci; 2021 Sep; 362(3):291-296. PubMed ID: 33857498
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA CCDC26 as a potential predictor biomarker contributes to tumorigenesis in pancreatic cancer.
Peng W; Jiang A
Biomed Pharmacother; 2016 Oct; 83():712-717. PubMed ID: 27470572
[TBL] [Abstract][Full Text] [Related]
9. LncRNA XIST Promotes Pancreatic Cancer Proliferation Through miR-133a/EGFR.
Wei W; Liu Y; Lu Y; Yang B; Tang L
J Cell Biochem; 2017 Oct; 118(10):3349-3358. PubMed ID: 28295543
[TBL] [Abstract][Full Text] [Related]
10. High Expression of Cell Division Cycle 42 Promotes Pancreatic Cancer Growth and Predicts Poor Outcome of Pancreatic Cancer Patients.
Yang D; Zhang Y; Cheng Y; Hong L; Wang C; Wei Z; Cai Q; Yan R
Dig Dis Sci; 2017 Apr; 62(4):958-967. PubMed ID: 28181096
[TBL] [Abstract][Full Text] [Related]
11. HOXD9‑induced SCNN1A upregulation promotes pancreatic cancer cell proliferation, migration and predicts prognosis by regulating epithelial‑mesenchymal transformation.
Chang J; Hu X; Nan J; Zhang X; Jin X
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34558641
[TBL] [Abstract][Full Text] [Related]
12. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of
Lyu PW; Xu XD; Zong K; Qiu XG
Gland Surg; 2022 Jan; 11(1):115-124. PubMed ID: 35242674
[TBL] [Abstract][Full Text] [Related]
14. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
15. miR-331-3p functions as an oncogene by targeting ST7L in pancreatic cancer.
Chen X; Luo H; Li X; Tian X; Peng B; Liu S; Zhan T; Wan Y; Chen W; Li Y; Lu Z; Huang X
Carcinogenesis; 2018 Jul; 39(8):1006-1015. PubMed ID: 29850766
[TBL] [Abstract][Full Text] [Related]
16. hsa_circRNA_001587 upregulates SLC4A4 expression to inhibit migration, invasion, and angiogenesis of pancreatic cancer cells via binding to microRNA-223.
Zhang X; Tan P; Zhuang Y; Du L
Am J Physiol Gastrointest Liver Physiol; 2020 Dec; 319(6):G703-G717. PubMed ID: 32878470
[TBL] [Abstract][Full Text] [Related]
17. UGT1A Gene Family Members Serve as Potential Targets and Prognostic Biomarkers for Pancreatic Cancer.
Feng L; Wang Y; Qin J; Fu Y; Guo Z; Zhang J; He G; Jiang Z; Xu X; Zhou C; Gao Y
Biomed Res Int; 2021; 2021():6673125. PubMed ID: 34595239
[TBL] [Abstract][Full Text] [Related]
18. CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer.
Liu C; Fu X; Zhong Z; Zhang J; Mou H; Wu Q; Sheng T; Huang B; Zou Y
Dig Dis Sci; 2017 Sep; 62(9):2376-2385. PubMed ID: 28646284
[TBL] [Abstract][Full Text] [Related]
19. Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer.
Tanaka N; Yamada S; Sonohara F; Suenaga M; Hayashi M; Takami H; Niwa Y; Hattori N; Iwata N; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Fujii T; Kodera Y
Sci Rep; 2018 Jun; 8(1):9846. PubMed ID: 29959362
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression.
Yan J; Jia Y; Chen H; Chen W; Zhou X
J Exp Clin Cancer Res; 2019 Sep; 38(1):390. PubMed ID: 31488171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]